Vivo Bio Tech Limited

Company Profile

Vivo Bio Tech Limited had its IPO on under the ticker symbol 511509.

The company operates in the Healthcare sector and Biotechnology industry. Vivo Bio Tech Limited has a staff strength of 175 employees.

Stock update

Shares of Vivo Bio Tech Limited opened at ₹34.12 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹31 - ₹34.12, and closed at ₹31.19.

This is a -5.48% slip from the previous day's closing price.

A total volume of 22,147 shares were traded at the close of the day’s session.

In the last one week, shares of Vivo Bio Tech Limited have increased by +11.39%.

Vivo Bio Tech Limited's Key Ratios

Vivo Bio Tech Limited has a market cap of ₹638.58 million, indicating a price to book ratio of 1.559 and a price to sales ratio of 1.008.

In the last 12-months Vivo Bio Tech Limited’s revenue was ₹511.61 million with a gross profit of ₹445.91 million and an EBITDA of ₹112.13 million. The EBITDA ratio measures Vivo Bio Tech Limited's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Vivo Bio Tech Limited’s operating margin was 12.53% while its return on assets stood at 4.82% with a return of equity of 0%.

In Q2, Vivo Bio Tech Limited’s quarterly earnings growth was a negative -19.1% while revenue growth was a negative 31.4%.

Vivo Bio Tech Limited’s PE and PEG Ratio

Forward PE

0

Trailing PE

12.2171

PEG

Its diluted EPS in the last 12-months stands at ₹3.268 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Vivo Bio Tech Limited’s profitability.

Vivo Bio Tech Limited stock is trading at a EV to sales ratio of 1.4624 and a EV to EBITDA ratio of 6.4321. Its price to sales ratio in the trailing 12-months stood at 1.008.

Vivo Bio Tech Limited stock pays annual dividends of ₹ per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

₹1.23 billion

Total Liabilities

₹249.69 million

Operating Cash Flow

₹-39975000.00

Capital Expenditure

₹39.98 million

Dividend Payout Ratio

0%

Vivo Bio Tech Limited ended 2024 with ₹1.23 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹1.23 billion while shareholder equity stood at ₹518.73 million.

Vivo Bio Tech Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹249.69 million in other current liabilities, 149035000.00 in common stock, ₹369.70 million in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹0 and cash and short-term investments were ₹13.75 million. The company’s total short-term debt was ₹0 while long-term debt stood at ₹430.92 million.

Vivo Bio Tech Limited’s total current assets stands at ₹317.91 million while long-term investments were ₹0 and short-term investments were ₹0. Its net receivables were ₹123.80 million compared to accounts payable of ₹0 and inventory worth ₹79.73 million.

In 2024, Vivo Bio Tech Limited's operating cash flow was ₹-39975000.00 while its capital expenditure stood at ₹39.98 million.

Comparatively, Vivo Bio Tech Limited paid ₹0 in dividends in 2024.

Other key metrics

Current Trading Price

₹31.19

52-Week High

₹43

52-Week Low

₹18.11

Analyst Target Price

₹

Vivo Bio Tech Limited stock is currently trading at ₹31.19 per share. It touched a 52-week high of ₹43 and a 52-week low of ₹43. Analysts tracking the stock have a 12-month average target price of ₹.

Its 50-day moving average was ₹28.24 and 200-day moving average was ₹27.63 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 8871.5% of the company’s stock are held by insiders while 0% are held by institutions.